- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-26-0283482

Rexha Pharmaceuticals Private Limited
About Rexha Pharmaceuticals Private Limited
Data last updated:
Rexha Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 04 March 2022.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2022PTC209097.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Taheruzzaman Khan Abiduzzaman Khan and Haris Safwan Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 15A A – Building Fourth Floor City Vista Fountain Road Kharadi, Pune, Maharashtra, India – 411014.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.01 Lakh. For the same year it recorded a net profit of ₹23,707 (net margin 3.9%) and EBITDA of ₹23,707 (EBITDA margin 3.9%).
Court records list 1 case involving the company, including 1 filed against it.
Rexha Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0283482).
Company details
Recognitions & Rankings of Rexha Pharmaceuticals
Contact details
Rexha Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressOffice No. 15A A – Building Fourth Floor City Vista Fountain Road Kharadi, Pune, Maharashtra, India – 411014
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rexha Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Rexha Pharmaceuticals Private Limited, buy the company report.
Financials of Rexha Pharmaceuticals Private Limited
FY 2025 filings availableRexha Pharmaceuticals Private Limited reported revenue of ₹6.01 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹23,707 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹23,707 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.9% | |||
| Net Profit Margin | 3.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Rexha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rexha Pharmaceuticals Private Limited
Rexha Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Taheruzzaman Khan Abiduzzaman Khan | Director | 04 Mar 2022 | 4 Years 7 Months | Current |
| Haris Safwan Khan Also directs: Health Upliftment Dignity Assistance Foundation | Director | 04 Mar 2022 | 4 Years 7 Months | Current |
| Nawab Naim Ahmad Khan Niyazi | Director | 04 Mar 2022 | 4 Years 7 Months | Current |
| Yasmin Jamal Ansari Hasan Ul Banna | Director | 01 Mar 2023 | 3 Years 7 Months | Current |
Legal cases
Rexha Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed against the company by Alkem Laboratories Ltd | Disposed |
To see the full case history of Rexha Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rexha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rexha Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rexha Pharmaceuticals Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Yasmin Jamal Ansari Hasan Ul Banna was appointed as Director on 01 Mar 2023.
Frequently asked questions
Rexha Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 04 March 2022 (4+ years old) and is registered under CIN U24290PN2022PTC209097.
Rexha Pharmaceuticals has 4 current directors:
- Taheruzzaman Khan Abiduzzaman Khan - Director
- Haris Safwan Khan - Director
- Nawab Naim Ahmad Khan Niyazi - Director
- Yasmin Jamal Ansari Hasan Ul Banna - Director
The latest financial statements of Rexha Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Rexha Pharmaceuticals is U24290PN2022PTC209097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rexha Pharmaceuticals has 1 court case on record: 1 filed against it.
Rexha Pharmaceuticals was incorporated on 04 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
Yasmin Jamal Ansari Hasan Ul Banna was appointed as Director on 01 Mar 2023. Haris Safwan Khan was appointed as Director on 04 Mar 2022. Nawab Naim Ahmad Khan Niyazi was appointed as Director on 04 Mar 2022. Rexha Pharmaceuticals has 4 board changes on record in total.
Yes, Rexha Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0283482).
The registered office of Rexha Pharmaceuticals is at Office No. 15A A – Building Fourth Floor City Vista Fountain Road Kharadi, Pune, Maharashtra, India – 411014.
Rexha Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.

